A detailed history of Sanctuary Wealth Management, L.L.C. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sanctuary Wealth Management, L.L.C. holds 390 shares of GILD stock, worth $34,351. This represents 0.02% of its overall portfolio holdings.

Number of Shares
390
Previous 390 -0.0%
Holding current value
$34,351
Previous $28,000 7.14%
% of portfolio
0.02%
Previous 0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$62.32 - $89.47 $24,304 - $34,893
390 New
390 $33,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sanctuary Wealth Management, L.L.C. Portfolio

Follow Sanctuary Wealth Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanctuary Wealth Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Sanctuary Wealth Management, L.L.C. with notifications on news.